Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
NOT FOR DISTRIBUTION TO THE UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, April 10, 2026 (GLOBE NEWSWIRE) -- Stack Capital Group Inc. (the "Company") (TSX:STCK...
-
LIMASSOL, Cyprus, April 10, 2026 (GLOBE NEWSWIRE) -- Robin Energy Ltd. (NASDAQ: RBNE), (“Robin”, or the “Company”), an international ship-owning company providing energy transportation services...
-
IRVINE, CA, April 10, 2026 (GLOBE NEWSWIRE) -- ATIF Holdings Limited (NASDAQ: ZBAI), a financial consulting firm serving small and medium‑sized enterprises, today announced that its wholly owned...
-
NE PAS DIFFUSER, PUBLIER OU DISTRIBUER, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS D’AMÉRIQUE, AU CANADA, AU JAPON OU EN AUSTRALIE, OU DANS TOUTE AUTRE JURIDICTION OU IL EST ILLÉGAL DE DIFFUSER, DE...
-
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO...
-
Final sponsorship opportunities available for Data Centre LIVE 2026, bringing together global leaders to explore AI, energy, and infrastructure innovation
-
NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- NetworkNewsWire Editorial Coverage: Escalating geopolitical tensions and renewed disruptions to key shipping corridors, particularly around the Strait of...
-
MIAMI BEACH, Fla., April 10, 2026 (GLOBE NEWSWIRE) -- Thomas J. Herzfeld Advisors, Inc., investment advisor to Herzfeld Credit Income Fund, Inc. (NASDAQ: HERZ) (the “Fund”), today announced the...
-
HOUSTON, April 10, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with...
-
Financing secures path to first NDA submission for buntanetap6-Month symptomatic data readout anticipated Q1 2027Alzheimer’s disease Phase 3 trial 75% enrolledParkinson's disease open-label study 28%...